Induction of Mdm2 and enhancement of cell survival by bFGF

Eitan Shaulian, Dalia Resnitzky, Ohad Shifman, Giovanni Blandino, Abraham Amsterdam, Avner Yayon, Moshe Oren

Research output: Contribution to journalArticlepeer-review

Abstract

Basic fibroblast growth factor (bFGF) can exert mitogenic and viability-promoting effects in a wide range of biological systems. The biochemical activities mediating the cell survival function of bFGF are largely unknown. We report here that exposure of fibroblasts to bFGF, which confers upon them increased survival, also causes at the same time an increase in cellular levels of the Mdm2 oncoprotein. Cells constitutively exposed to a bFGF autocrine loop are more refractory to killing by cisplatin. This increased chemoresistance coincides with elevated Mdm2 and reduced activation of the endogenous p53, resulting in inefficient transcriptional activation of the bax gene promoter. Importantly, unlike Mdm2 accumulation in fibroblasts exposed to DNA damage, induction of Mdm2 by bFGF does not occur through a p53-mediated pathway. The role of p53 in DNA damage-induced apoptosis and the ability of Mdm2 to block p53-mediated cell death are well established. These findings therefore suggest that induction of Mdm2 and the subsequent inhibition of p53 function may contribute, at least partially, to the anti-apoptotic effects of bFGF and possibly some other survival factors.

Original languageEnglish
Pages (from-to)2717-2725
Number of pages9
JournalOncogene
Volume15
Issue number22
Publication statusPublished - 1997

Keywords

  • Apoptosis
  • bFGF
  • Cisplatin
  • Mdm2
  • p53

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Fingerprint Dive into the research topics of 'Induction of Mdm2 and enhancement of cell survival by bFGF'. Together they form a unique fingerprint.

Cite this